Cargando…

Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors

Recombinant adeno-associated viruses (rAAVs) are promising gene delivery vectors in the emerging field of in vivo gene therapies. To ensure their consistent quality during manufacturing and process development, multiple analytical techniques have been proposed for the characterization and quantifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Heckel, Jakob, Martinez, Andres, Elger, Carsten, Haindl, Markus, Leiss, Michael, Ruppert, Raphael, Williams, Chris, Hubbuch, Jürgen, Graf, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690635/
https://www.ncbi.nlm.nih.gov/pubmed/38046198
http://dx.doi.org/10.1016/j.omtm.2023.101148
_version_ 1785152563626115072
author Heckel, Jakob
Martinez, Andres
Elger, Carsten
Haindl, Markus
Leiss, Michael
Ruppert, Raphael
Williams, Chris
Hubbuch, Jürgen
Graf, Tobias
author_facet Heckel, Jakob
Martinez, Andres
Elger, Carsten
Haindl, Markus
Leiss, Michael
Ruppert, Raphael
Williams, Chris
Hubbuch, Jürgen
Graf, Tobias
author_sort Heckel, Jakob
collection PubMed
description Recombinant adeno-associated viruses (rAAVs) are promising gene delivery vectors in the emerging field of in vivo gene therapies. To ensure their consistent quality during manufacturing and process development, multiple analytical techniques have been proposed for the characterization and quantification of rAAV capsids. Despite their indisputable capabilities for performing this task, current analytical methods are rather time-consuming, material intensive, complicated, and costly, restricting their suitability for process development in which time and sample throughput are severe constraints. To eliminate this bottleneck, we introduce here an affinity-based high-performance liquid chromatography method that allows the determination of the capsid titer and the full/empty ratio of rAAVs within less than 5 min. By packing the commercially available AAVX affinity resin into small analytical columns, the rAAV fraction of diverse serotypes can be isolated from process-related impurities and analyzed by UV and fluorescence detection. As demonstrated by both method qualification data and side-by-side comparison with AAV enzyme-linked immunosorbent assay results for rAAV8 samples as well as by experiments using additional rAAV2, rAAV8, and rAAV9 constructs, our approach showed good performance, indicating its potential as a fast, simple and efficient tool for supporting the development of rAAV gene therapies.
format Online
Article
Text
id pubmed-10690635
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-106906352023-12-02 Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors Heckel, Jakob Martinez, Andres Elger, Carsten Haindl, Markus Leiss, Michael Ruppert, Raphael Williams, Chris Hubbuch, Jürgen Graf, Tobias Mol Ther Methods Clin Dev Original Article Recombinant adeno-associated viruses (rAAVs) are promising gene delivery vectors in the emerging field of in vivo gene therapies. To ensure their consistent quality during manufacturing and process development, multiple analytical techniques have been proposed for the characterization and quantification of rAAV capsids. Despite their indisputable capabilities for performing this task, current analytical methods are rather time-consuming, material intensive, complicated, and costly, restricting their suitability for process development in which time and sample throughput are severe constraints. To eliminate this bottleneck, we introduce here an affinity-based high-performance liquid chromatography method that allows the determination of the capsid titer and the full/empty ratio of rAAVs within less than 5 min. By packing the commercially available AAVX affinity resin into small analytical columns, the rAAV fraction of diverse serotypes can be isolated from process-related impurities and analyzed by UV and fluorescence detection. As demonstrated by both method qualification data and side-by-side comparison with AAV enzyme-linked immunosorbent assay results for rAAV8 samples as well as by experiments using additional rAAV2, rAAV8, and rAAV9 constructs, our approach showed good performance, indicating its potential as a fast, simple and efficient tool for supporting the development of rAAV gene therapies. American Society of Gene & Cell Therapy 2023-11-02 /pmc/articles/PMC10690635/ /pubmed/38046198 http://dx.doi.org/10.1016/j.omtm.2023.101148 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Heckel, Jakob
Martinez, Andres
Elger, Carsten
Haindl, Markus
Leiss, Michael
Ruppert, Raphael
Williams, Chris
Hubbuch, Jürgen
Graf, Tobias
Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title_full Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title_fullStr Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title_full_unstemmed Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title_short Fast HPLC-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
title_sort fast hplc-based affinity method to determine capsid titer and full/empty ratio of adeno-associated viral vectors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690635/
https://www.ncbi.nlm.nih.gov/pubmed/38046198
http://dx.doi.org/10.1016/j.omtm.2023.101148
work_keys_str_mv AT heckeljakob fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT martinezandres fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT elgercarsten fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT haindlmarkus fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT leissmichael fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT ruppertraphael fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT williamschris fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT hubbuchjurgen fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors
AT graftobias fasthplcbasedaffinitymethodtodeterminecapsidtiterandfullemptyratioofadenoassociatedviralvectors